| Dominion Income Trust 1 (DN1) ORDINARY UNITS FULLY PAID |
Financials |
$339 |
Update - Dividend/Distribution - DN1
|
19 Oct 2026 9:37AM |
$97.830 |
$98.250 |
risen by
0.43%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$481 |
Weekly NTA 16.10.2026
|
19 Oct 2026 9:37AM |
$2.280 |
$2.160 |
fallen by
5.26%
|
|
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$1,301 |
Icon Continues Rapid Growth with High-Grade Gold Intercepts
|
19 Oct 2026 9:37AM |
$4.060 |
$3.880 |
fallen by
4.43%
|
|
BNZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Benz Mining reported 68 RC holes for 25,776 m from the Icon gold camp at the Glenburgh Gold Project in Western Australia.
- Systematic 50 m by 25 m drilling has delineated a 100–200 m wide mineralised system over the first 1 km of the known 3 km Icon trend.
- Mineralisation has been defined to vertical depths exceeding 500 m.
- Icon comprises multiple stacked high-grade gold lenses averaging about 30–50 m in width within a broader mineralised halo.
- Highlighted intercepts include 46 m at 6.5 g/t Au from 454 m in 26CN120.
- Other key intercepts include 42 m at 3.0 g/t Au and 39 m at 3.1 g/t Au in hole 26CN129.
- Additional strong results include 62 m at 1.5 g/t Au in 26CN125, 74 m at 1.0 g/t Au in 26CN126, 73 m at 1.1 g/t Au in 26CN130 and 68 m at 1.2 g/t Au in 26CN146.
- Broad mineralised intervals were also returned in 26CN147, 26CN148, 26CN149, 26CN176 and 26CN201.
- Benz interprets the mineralisation as structurally controlled by fold hinges and shear structures, with potential thickening down plunge.
- The remaining 2 km of the Icon trend is considered highly prospective because previous drilling, mapping and structural interpretation show continuation of the same favourable host rocks and structures.
- First-pass drilling across the eastern 2 km is nearing completion and further drilling updates are expected.
- A fourth exploration camp, around 3–4 km long, has been identified east of Hurricane and is expected to be drill tested soon.
- Benz is also progressing early development studies including geotechnical work, metallurgical testwork, water exploration, power demand modelling and infrastructure planning.
- The company is integrating structural measurements, lithogeochemistry and gold assays to support its geological model and future resource work.
- A maiden Mineral Resource Estimate for Glenburgh is targeted for Q1 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$84 |
Response to ASX Query Letter
|
19 Oct 2026 9:37AM |
$0.615 |
$0.610 |
fallen by
0.81%
|
|
CAM - Price-sensitive ASX Announcement
Full Release
Key Points
- CAM responded to ASX regarding its FY26 full-year report and KPMG’s qualified audit opinion.
- The qualification related to insufficient audit evidence for unlisted unit trusts valued at $36,205,754 as at 30 June 2026.
- The affected valuation also impacted related management fees, performance fees and accrued income.
- Directors said they relied on investment manager confirmations, underlying investment documents and some independent appraisals when approving the accounts.
- CAM considered the reported net asset values of the relevant unlisted trusts to be the best available estimate of fair value at 30 June 2026.
- The auditor’s additional evidence requests followed ASIC guidance issued in June 2026 on private credit valuations.
- CAM said the external investment manager could not provide all requested valuations and security verification within the FY26 audit timetable.
- The investment manager expects to complete its detailed review of unlisted investment valuations and reporting during November 2026, subject to outstanding information.
- CAM said it will disclose any material findings in accordance with its continuous disclosure obligations.
- CAM is engaging an external firm to independently review its private debt portfolio.
- That review will cover valuations, security arrangements, unit trust structures, documentation, governance and risk management practices.
- CAM said these steps are intended to support an unmodified review conclusion for the half-year ending 31 December 2026.
- The board confirmed it received the declaration from Clime Asset Management Pty Ltd under section 4.2 of the Corporate Governance Disclosure.
- CAM said the board made enquiries of its investment manager and auditors before approving the financial statements.
- CAM confirmed compliance with the ASX Listing Rules, including Listing Rule 3.1.
- CAM said the response to ASX was authorised and approved by the board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$78 |
NOVONIX AND POWERCO AMEND SUPPLY AGREEMENT
|
19 Oct 2026 9:36AM |
$0.084 |
$0.078 |
fallen by
7.14%
|
|
NVX - Price-sensitive ASX Announcement
Full Release
Key Points
- NOVONIX entered into an amended and restated supply framework agreement with PowerCo SE.
- The revised agreement replaces the binding offtake agreement announced on 25 November 2024.
- A new offtake agreement will be negotiated after NOVONIX completes PowerCo’s qualification process and obtains required industrial certifications.
- NOVONIX has achieved ISO 9001 certification and expects ISO 14001 certification in 2027.
- The timing of PowerCo qualification depends on market conditions.
- The previous November 2024 agreement covered a minimum supply of 32,000 tonnes over five years beginning in 2027.
- The original supply was intended for PowerCo’s St. Thomas, Ontario gigafactory.
- The amendment reflects changes in North American EV and battery markets, including demand, production timing, tariffs and regulation.
- NOVONIX said its focus is on completing qualification and proving commercial-scale production of high-performance synthetic graphite.
- The announcement highlights NOVONIX’s strategy to support a resilient North American battery materials supply chain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Weebit Nano Ltd (WBT) ORDINARY FULLY PAID |
Information Technology |
$575 |
Investor Update
|
19 Oct 2026 9:35AM |
$2.880 |
$2.370 |
fallen by
17.71%
|
|
| Boresight Ltd (BST) ORDINARY FULLY PAID |
Industrials |
$24 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
19 Oct 2026 9:35AM |
$0.200 |
$0.190 |
fallen by
5%
|
|
BST - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C for the quarter ended 30 September 2026 was released on 19 October 2026.
- Boresight Ltd reported cash and cash equivalents of A$5.39 million at 30 September 2026 with no debt.
- Unaudited Q1 FY27 revenue was about A$829,000, with lower deliveries reflecting the lumpy timing of defence procurement.
- The company transitioned from a build-to-order model toward a build-to-inventory model, with inventory rising to about A$1.45 million at 30 September 2026.
- A$962,516 was spent on materials in the quarter to build inventory and fulfil orders, bringing total stock purchases since listing to A$1,128,581.
- US production moved to a new 812 sqm Huntsville, Alabama facility, around 15 times larger than the previous US premises.
- Boresight invested about A$136,000 in expanding its US manufacturing facilities during the quarter, including additional 3D printing and supporting equipment.
- Production commenced at the Huntsville facility, with plans for high-volume capability by the end of Q2 FY27.
- The initial Huntsville fit-out is intended to support production of more than 5,000 BQ-400 aerial target drones per year.
- Boresight U.S., Inc. received a repeat purchase order worth US$383,275, approximately A$532,000, from Mountain Horse Solutions for the US National Training Centre at Fort Irwin.
- The North American order is around three times the value of the end customer’s previous order and includes more than 340 swarming-capable BQ-400 drones, Ground Control Stations and training.
- Delivery and payment for the North American order were expected in Q2 FY27.
- Boresight continued supporting the Australian Defence Force, including delivery of 120 BQ-400s for Counter-UAS training and ongoing support to Project LAND 156.
- The BS-350 capability continued development for ADF requirements under the Sovereign UAS Program contract, with next batch deliveries expected in Q2.
- Boresight supported demonstrations of BQ-400 swarming capability to Japanese Defence through a major Japanese trading house.
- The company prepared BF-100 and BQ-400 demonstrations for a NATO event in Europe and UK Ministry of Defence trials for the BQ-400 and BQ-750.
- Boresight became a registered supplier to Lockheed Martin through the Exostar Supplier Management Portal.
- The BQ-750 Block 2 was released to market on 6 July 2026, offering increased speed, endurance and payload capacity, and first orders were delivered.
- The BQ-750 Block 2 uses the same proprietary Ground Control Station as the BQ-400, allowing mixed-platform operations and swarming.
- Initial low-rate production of the BF-100 fixed-wing target drone commenced during the quarter for demonstration activities in the US and Europe.
- The BF-100 received strong customer interest in a US demonstration and was undergoing design-for-manufacturing work for low-cost, high-scale production.
- Boresight expanded its business development and marketing team with hires in Canberra and Huntsville.
- Production and delivery of BQ-400 drones continued across Australia, the United States, Germany and Sweden, with the 6300th unit manufactured and delivered during the quarter.
- Net cash used in operating activities was A$2.281 million, compared with A$0.90 million in Q4 FY26.
- Receipts from customers were A$1.098 million in the quarter.
- Payments for product manufacturing and operating costs were A$1.429 million, including significant stock and long-lead component purchases.
- Payments for property, plant and equipment were A$100,000, while financing outflows totalled A$115,000.
- Payments to related parties totalled A$130,000 and comprised directors’ fees and remuneration paid to directors and their associates.
- The Appendix 4C showed estimated funding of 2.4 quarters based on quarter-end cash and current operating cash outflow.
- Q2 FY27 priorities included completing the North American order, finishing the high-volume Huntsville facility, supplying BQ-750 Block 2 units for a major international counter-UAS activity and moving the BF-100 toward full-rate production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$37 |
High-Grade Gold Lode discovered at Cosmopolitan Gold Mine
|
19 Oct 2026 9:35AM |
$0.030 |
$0.024 |
fallen by
20%
|
|
ARI - Price-sensitive ASX Announcement
Full Release
Key Points
- Arika reported a new high-grade gold lode discovery at the Cosmopolitan Gold Mine in the Kookynie Gold Project, Western Australia.
- The new lode is a hangingwall structure located about 10–20m above the historically mined Cosmopolitan Main Reef.
- The discovery lies about 200m down-plunge beyond the main area of historical underground mining.
- Key drill result 26AKRC007 returned 5m @ 12.34g/t Au from 162m including 1m @ 49.92g/t Au and 1m @ 7.76g/t Au.
- Key drill result 26AKRC004 returned 9m @ 1.59g/t Au from 188m including 3m @ 4.48g/t Au.
- Hole 26AKRC004 also intersected the Cosmopolitan Main Reef with 9m @ 0.61g/t Au from 200m including 1m @ 3.87g/t Au.
- Arika said the gold-bearing shear zone is almost devoid of quartz, which may explain why historical miners overlooked it.
- The historical Cosmopolitan mine produced roughly 331,000 to 360,000 ounces of gold at an average grade of about 15g/t Au between discovery and 1922.
- The discovery opens a large under-explored target area within the Diamantina-Cosmopolitan-Cumberland trend.
- Historical deeper drilling by Nex Metals previously returned 3m @ 9.60g/t Au including 0.50m @ 55.70g/t Au in hole NXDD003.
- Additional encouraging results were reported from Irishman with 1m @ 11.77g/t Au from 63m, Welshman with 4m @ 6.34g/t Au from 16m, and Altona South with 4m @ 8.24g/t Au from 90m.
- Arika had completed about 100 RC holes for 12,000m at Kookynie, with about 8,000 samples still awaiting assays.
- The company said the drilling supports its strategy to grow gold inventory and progress toward a maiden Mineral Resource Estimate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NEXTDC Limited (NXT) ORDINARY FULLY PAID |
Information Technology |
$4,262 |
Trading Halt
|
19 Oct 2026 9:33AM |
$9.180 |
$5.610 |
fallen by
38.89%
|
|
NXT - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX placed NEXTDC Limited (ASX: NXT) in a trading halt on 19 October 2026 at the company’s request.
- The trading halt was requested pending a market announcement from NEXTDC.
- The reason for the request was a material update concerning a delay to the supply of power at the M3 Melbourne data centre.
- NEXTDC said it was assessing the impact of the delay, including on its FY27 financial guidance.
- The company sought the halt to manage its continuous disclosure obligations.
- NEXTDC stated that its board had not yet met to consider the M3 power delay and its implications.
- The halt was to remain until the earlier of the market announcement or the commencement of trading on Wednesday, 21 October 2026.
- NEXTDC expected to end the halt by making an announcement on the M3 power matter within two days.
- The request was made under ASX Listing Rule 17.1.
- The request letter was signed by Michael Helmer, Company Secretary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomos Limited (AMS) ORDINARY FULLY PAID |
Consumer Discretionary |
$13 |
Consolidation/Split - AMS
|
19 Oct 2026 9:33AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$10,334 |
Stockland 1Q27 Operational Update
|
19 Oct 2026 9:33AM |
$4.230 |
$4.250 |
risen by
0.47%
|
|
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$52 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
19 Oct 2026 9:33AM |
$0.085 |
$0.081 |
fallen by
4.71%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 FY27 covered the quarter ended 30 September 2026 and was announced on 19 October 2026.
- Record September UK Education revenue was A$375,908, up 79.9% on the prior corresponding period and 18.6% above the previous monthly record.
- New universities contributed A$159,094 of September revenue, while established universities contributed A$216,814.
- UK revenue for Q1 FY27 was A$827,469 versus A$682,400 in Q1 FY26, an increase of 21%.
- New universities implemented contributed 42% of revenue during the quarter.
- Six additional universities progressed into implementation across the UK and Europe.
- Fifteen US universities commenced implementation with TransferMate as the first cohort from the previously announced 283 US universities.
- The company reported 15 established universities, 7 onboarded universities and 21 in implementation stage at September 2026, totalling 43 university accounts.
- TransferMate had indicated the 15 US universities would be live by 31 December 2026.
- Cash receipts from customers were A$765,000 for the quarter.
- Net cash used in operating activities was A$611,000.
- Operating cash outflows included A$356,000 in product manufacturing and operating costs, A$833,000 in staff costs and A$205,000 in administration and corporate costs.
- Government grants and tax incentives received in the quarter were A$20,000.
- Net cash from investing activities was A$32,000, including redemption of a refundable security deposit.
- Net cash from financing activities was A$881,000, including A$928,000 from equity securities and A$47,000 of borrowings repaid.
- Cash and cash equivalents at quarter end were A$747,000.
- Payments to related parties and their associates totalled A$25,000.
- Total financing facilities were A$1.4 million and were fully drawn at quarter end.
- The facilities comprised a A$400,000 unsecured loan from Plutus Pty Limited at 15% per annum maturing in March 2027 and a A$1.0 million secured loan from Riverfort Capital at 9.6% per annum maturing in March 2027, repayable in equity at the lender’s choice.
- Estimated quarters of funding available was 1.2 quarters.
- IODM expects stronger Q2 FY27 cash flows due to the Northern Hemisphere academic year collections and an anticipated A$500,000 R&D tax incentive receipt.
- The company said October is traditionally its largest revenue month, with related revenue expected to be reflected in November cash receipts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orbital Corporation Limited (OEC) ORDINARY FULLY PAID |
Industrials |
$22 |
Notice of Annual General Meeting/Proxy Form
|
19 Oct 2026 9:33AM |
$0.110 |
$0.125 |
risen by
13.64%
|
|
| Surefire Resources NL (SRN) ORDINARY FULLY PAID |
Materials |
$3 |
Application for quotation of securities - SRN
|
19 Oct 2026 9:33AM |
$0.017 |
$0.015 |
fallen by
11.76%
|
|
| WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$196 |
Kym Evans Appendix 3Y
|
19 Oct 2026 9:32AM |
$1.080 |
$1.090 |
risen by
0.93%
|
|
| WAM Capital Limited (WAM) ORDINARY FULLY PAID |
Financials |
$1,148 |
Geoff Wilson Appendix 3Y
|
19 Oct 2026 9:31AM |
$1.010 |
$1.000 |
fallen by
0.99%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$96 |
USAMRIID Marburg study advances towards dosing
|
19 Oct 2026 9:31AM |
$0.345 |
$0.325 |
fallen by
5.80%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals confirmed 22 non-human primates completed screening and preparation for the planned USAMRIID Marburg study.
- The planned study will use 20 animals, with two additional primates available as reserves.
- All animals passed rigorous health and suitability assessments and completed specialised training including acclimatisation to jackets and tethering systems.
- Dosing is anticipated to commence in Q4 CY2026.
- The USAMRIID study will evaluate Galidesivir against the Angola strain of Marburg virus.
- Treatment will begin 24 or 48 hours after exposure and be administered intravenously over 14 days.
- The primary endpoint is survival at 28 days post-exposure, supported by viral load, clinical signs, pharmacokinetics and other disease-related measures.
- The study is being conducted under a CRADA with USAMRIID and The Geneva Foundation in BSL-4 facilities.
- Study observations are expected to conclude about 30 days after commencement, with topline results to follow analysis.
- Island said the study is a key step in its FDA Animal Rule development pathway for Galidesivir.
- Data from the study is intended to support dose optimisation and design of a planned pivotal confirmatory efficacy study.
- The USAMRIID study is designed to complement a separate 12-NHP Texas Biomed study examining treatment after clinical disease onset.
- The broader Galidesivir program builds on more than US$70 million of prior US Government investment.
- Previously generated data cited by the company showed about 94% survival in Galidesivir-treated animals infected with the Marburg Musoke strain, versus no survival in placebo-treated controls.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
Update - Notification of buy-back - ATG
|
19 Oct 2026 9:30AM |
$0.390 |
$0.380 |
fallen by
2.56%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,417 |
BKI Weekly NTA 16 October 2026
|
19 Oct 2026 9:30AM |
$1.775 |
$1.755 |
fallen by
1.13%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$114 |
Quarterly Activities Report and Appendix 4C
|
19 Oct 2026 9:30AM |
$0.470 |
$0.440 |
fallen by
6.38%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- PROTECT-MI Phase IIa expanded from one to four activated hospital sites during the quarter, with three patients dosed and a total of eight sites expected by the end of November 2026.
- Nyrada expects final patient dosing in PROTECT-MI in mid-2027 and preliminary trial results in Q3/Q4 CY2027 after follow-up and data review.
- US FDA pre-IND feedback for Xolatryp in the PROTECT-MI program raised no major issues, supporting an IND submission in 1HCY2027.
- Preclinical oncology data showed Xolatryp provided significant and sustained cardioprotection in a doxorubicin-induced cardiomyopathy model, with effect size comparable to dexrazoxane.
- Nyrada commenced design of a Phase Ib oncology clinical trial after the end of the quarter.
- The company began designing a preclinical MCAO stroke study to support future Phase IIa development in ischaemic stroke.
- The US Patent Office granted a composition of matter patent over Xolatryp, providing US protection for the compound and analogues for 20 years from the September 2024 filing date.
- Cash and cash equivalents at 30 September 2026 were A$13.716 million, up from A$8.385 million at 30 June 2026.
- Net cash used in operating activities for the quarter was A$1.221 million, including research and development of A$568,000, staff costs of A$327,000 and administration and corporate costs of A$411,000.
- Nyrada received A$6.875 million from equity issuance during the quarter, A$100,000 from option exercises and incurred A$413,000 in transaction costs.
- The company reported estimated funding runway of 11.23 quarters based on quarter-end cash and current operating cash outflows.
- Related party payments disclosed in Appendix 4C were A$220,000, covering Chair and Non-Executive Director fees and CEO/Managing Director salary and superannuation.
- Nyrada announced a A$12.0 million placement before costs at A$0.62 per CDI, with A$5.125 million of director participation subject to CDI holder approval, and launched an SPP to raise up to a further A$2.0 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anson Resources Limited (ASN) ORDINARY FULLY PAID |
Materials |
$57 |
ASN Applies for the State Park Mineral Rights at Green River
|
19 Oct 2026 9:29AM |
$0.037 |
$0.035 |
fallen by
5.41%
|
|
ASN - Price-sensitive ASX Announcement
Full Release
Key Points
- Anson Resources applied for mineral rights under Green River State Park at its Green River Lithium Project in Utah.
- The application covers 114.4 acres or 0.46 km2 of prospective lithium-rich brine ground.
- The new tenure is within the current Indicated JORC Resource Area of Influence.
- If granted, the land would increase the overall Green River project area by 0.53%.
- If granted, the land would increase the Indicated JORC Resource AOI by 2.1%.
- The State Park ground is near the Bosydaba#1 well and is considered geologically similar to nearby lithium-bearing brine areas.
- Anson said the Leadville Limestone Formation beneath the area is about 680 to 750 feet thick and offers upside for future JORC estimation.
- The company’s strategy is to grow the Green River JORC estimate without additional drilling, reducing cost and timing.
- The conceptual Exploration Target for the State Park lease is 6.701 million to 6.892 million tonnes of brine at 100 to 130 ppm lithium.
- The Exploration Target equates to 670 to 896 tonnes of lithium or 3,567 to 4,769 tonnes of lithium carbonate.
- The company noted that an Exploration Target is not a Mineral Resource and remains conceptual in nature.
- Anson plans to include the State Park area in a future JORC resource review if the application is granted.
- The JORC upgrade is intended to support the Definitive Feasibility Study and funding pathway for the Green River Lithium Project.
- The announcement includes JORC Table 1 disclosures covering sampling methods, assay procedures, tenure, geology and further work.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$84 |
Update - Notification of buy-back - CAM
|
19 Oct 2026 9:29AM |
$0.615 |
$0.610 |
fallen by
0.81%
|
|
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$252 |
Todd Abbott appointed as Managing Director
|
19 Oct 2026 9:28AM |
$0.225 |
$0.190 |
fallen by
15.56%
|
|
TBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Todd Abbott was appointed Managing Director of Tamboran Resources Corporation while continuing as Chief Executive Officer, effective 19 October 2026.
- The appointment formalises Abbott’s executive leadership at Board level as Tamboran moves from appraisal into development.
- Abbott has more than 25 years of upstream oil and gas experience spanning unconventional shale operations, strategy, infrastructure, business planning and corporate finance.
- Chair Richard Stoneburner said Tamboran is advancing its strategy to supply gas from the Beetaloo Basin to the Northern Territory, Australia’s east coast and Asia Pacific markets.
- Abbott said the company is in a transformative period and highlighted first gas sales from the Beetaloo to the Northern Territory gas market.
- Tamboran stated that the material terms of Abbott’s appointment remain unchanged from the ASX announcement dated 12 January 2026.
- Tamboran describes itself as a growth-focused natural gas exploration and production company with approximately 2.8 million net prospective acres in the Beetaloo Basin.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$84 |
Update - Notification of buy-back - CAMG
|
19 Oct 2026 9:28AM |
$0.615 |
$0.610 |
fallen by
0.81%
|
|
| BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$28 |
BREASTESTplus Research Presented at Lipidomic Conference
|
19 Oct 2026 9:27AM |
$0.079 |
$0.075 |
fallen by
5.06%
|
|
Call 1300 880 160
Start a chat
Schedule a call
